{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T13:12:10Z","timestamp":1761311530567,"version":"3.44.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:00:00Z","timestamp":1565308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jviromet.2019.113714","type":"journal-article","created":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T09:40:03Z","timestamp":1565516403000},"page":"113714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Enhancing Hepatitis C virus pseudoparticles infectivity through p7NS2 cellular expression"],"prefix":"10.1016","volume":"274","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2123-5197","authenticated-orcid":false,"given":"Hugo R.","family":"Soares","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7975-060X","authenticated-orcid":false,"given":"Marina","family":"Ferreira-Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana I.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateusz","family":"Marchel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula M.","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana S.","family":"Coroadinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2019.113714_bib0005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.virusres.2013.06.008","article-title":"Evidence suggesting that HCV p7 protects E2 glycoprotein from premature degradation during virus production","volume":"176","author":"Atoom","year":"2013","journal-title":"Virus Res."},{"key":"10.1016\/j.jviromet.2019.113714_bib0010","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-1-59745-394-3_21","article-title":"Studying HCV cell entry with HCV pseudoparticles (HCVpp)","volume":"510","author":"Bartosch","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jviromet.2019.113714_bib0015","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20021756","article-title":"Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes","volume":"197","author":"Bartosch","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jviromet.2019.113714_bib0020","doi-asserted-by":"crossref","first-page":"8217","DOI":"10.1128\/JVI.79.13.8217-8229.2005","article-title":"An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies","volume":"79","author":"Bartosch","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2019.113714_bib0025","doi-asserted-by":"crossref","first-page":"41624","DOI":"10.1074\/jbc.M305289200","article-title":"Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor","volume":"278","author":"Bartosch","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jviromet.2019.113714_bib0030","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.jhep.2014.09.009","article-title":"A prophylactic hepatitis C virus vaccine: a distant peak still worth climbing","volume":"61","author":"Baumert","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jviromet.2019.113714_bib0035","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1099\/vir.0.054338-0","article-title":"Mutations in hepatitis C virus p7 reduce both the egress and infectivity of assembled particles via impaired proton channel function","volume":"94","author":"Bentham","year":"2013","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jviromet.2019.113714_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000978","article-title":"Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors","volume":"6","author":"Bitzegeio","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jviromet.2019.113714_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002144","article-title":"A concerted action of hepatitis C virus p7 and nonstructural protein 2 regulates core localization at the endoplasmic reticulum and virus assembly","volume":"7","author":"Boson","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jviromet.2019.113714_bib0050","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.bpj.2016.04.018","article-title":"Patch-clamp study of hepatitis C p7 channels reveals genotype-specific sensitivity to inhibitors","volume":"110","author":"Breitinger","year":"2016","journal-title":"Biophys. J."},{"key":"10.1016\/j.jviromet.2019.113714_bib0055","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1089\/hum.2009.165","article-title":"Integrated strategy for the production of therapeutic retroviral vectors","volume":"22","author":"Carrondo","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jviromet.2019.113714_bib0060","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.virol.2015.03.014","article-title":"Advances in experimental systems to study hepatitis C virus in vitro and in vivo","volume":"479\u2013480","author":"Catanese","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2019.113714_bib0065","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jhep.2016.06.019","article-title":"Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis","volume":"65","author":"Cheung","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jviromet.2019.113714_bib0070","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jbiotec.2006.01.037","article-title":"The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange","volume":"124","author":"Coroadinha","year":"2006","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jviromet.2019.113714_bib0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006774","article-title":"The amino-terminus of the hepatitis C virus (HCV) p7 viroporin and its cleavage from glycoprotein E2-p7 precursor determine specific infectivity and secretion levels of HCV particle types","volume":"13","author":"Denolly","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jviromet.2019.113714_bib0080","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/978-1-59745-394-3_32","article-title":"Detection of neutralizing antibodies with HCV pseudoparticles (HCVpp)","volume":"510","author":"Dreux","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jviromet.2019.113714_bib0085","doi-asserted-by":"crossref","first-page":"8346","DOI":"10.1128\/JVI.00192-15","article-title":"New insights into the understanding of hepatitis C virus entry and cell-to-Cell transmission by using the ionophore monensin A","volume":"89","author":"F\u00e9n\u00e9ant","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2019.113714_bib0090","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/hep.22555","article-title":"Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel","volume":"48","author":"Griffin","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jviromet.2019.113714_bib0095","doi-asserted-by":"crossref","first-page":"12567","DOI":"10.1073\/pnas.0906760106","article-title":"Plugging the holes in hepatitis C virus antiviral therapy","volume":"106","author":"Griffin","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jviromet.2019.113714_bib0100","doi-asserted-by":"crossref","first-page":"16741","DOI":"10.1074\/jbc.M212602200","article-title":"Identification of a key determinant of hepatitis C virus cell culture adaptation in domain II of NS3 helicase","volume":"278","author":"Grobler","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jviromet.2019.113714_bib0105","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.vaccine.2012.05.025","article-title":"Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice","volume":"31","author":"Huret","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2019.113714_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0149064","article-title":"Hepatitis C virus resistance to carbohydrate-binding agents","volume":"11","author":"Izquierdo","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jviromet.2019.113714_bib0115","doi-asserted-by":"crossref","first-page":"8374","DOI":"10.1128\/JVI.00690-07","article-title":"Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus","volume":"81","author":"Jones","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2019.113714_bib0120","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1128\/JVI.01534-06","article-title":"The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells","volume":"81","author":"Koutsoudakis","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2019.113714_bib0125","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1128\/JVI.79.10.6023-6034.2005","article-title":"Human Serum Facilitates Hepatitis C Virus Infection, and Neutralizing Responses Inversely Correlate with Viral Replication Kinetics at the Acute Phase of Hepatitis C Virus Infection","volume":"79","author":"Lavillette","year":"2005","journal-title":"J Virol."},{"key":"10.1016\/j.jviromet.2019.113714_bib0130","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.bbalip.2016.06.011","article-title":"Hepatitis C virus p7 mediates membrane-to-membrane adhesion","volume":"1861","author":"Lee","year":"2016","journal-title":"Biochim. Biophys. Acta - Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.jviromet.2019.113714_bib0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.antiviral.2017.02.014","article-title":"Current therapy for chronic hepatitis C: the role of direct-acting antivirals","volume":"142","author":"Li","year":"2017","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jviromet.2019.113714_bib0140","first-page":"1","article-title":"Tannic acid inhibits hepatitis C virus entry into Huh7.5 cells","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jviromet.2019.113714_bib0145","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1128\/JVI.00826-16","article-title":"Release of infectious hepatitis C virus from Huh7 cells occurs via a trans-golgi network-to-endosome pathway independent of very-low-density lipoprotein secretion","volume":"90","author":"Mankouri","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2019.113714_bib0150","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1073\/pnas.0501275102","article-title":"Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1","volume":"102","author":"Meunier","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jviromet.2019.113714_bib0155","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1128\/JVI.78.6.2994-3002.2004","article-title":"Characterization of functional hepatitis C virus envelope glycoproteins","volume":"78","author":"Op De Beeck","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2019.113714_bib0160","doi-asserted-by":"crossref","DOI":"10.1002\/0471141755.ph13b04s51","article-title":"Generation and quantitation of infectious hepatitis C virus derived from cell culture (HCVcc)","author":"Paulson","year":"2010","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.jviromet.2019.113714_bib0165","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jviromet.2013.06.024","article-title":"Fetal bovine serum inhibits hepatitis C virus attachment to host cells","volume":"193","author":"Qin","year":"2013","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2019.113714_bib0170","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/bit.24410","article-title":"Adaptation of retrovirus producer cells to serum deprivation: implications in lipid biosynthesis and vector production","volume":"109","author":"Rodrigues","year":"2012","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jviromet.2019.113714_bib0175","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ymthe.2005.12.003","article-title":"A new generation of retroviral producer cells: predictable and stable virus production by Flp-mediated site-specific integration of retroviral vectors","volume":"14","author":"Schucht","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jviromet.2019.113714_bib0180","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1128\/JVI.01909-07","article-title":"Identification of host proteins associated with retroviral vector particles by proteomic analysis of highly purified vector preparations","volume":"82","author":"Segura","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2019.113714_bib0185","doi-asserted-by":"crossref","first-page":"11255","DOI":"10.1128\/JVI.01807-13","article-title":"Efficiency of E2-p7 processing modulates production of infectious hepatitis C virus","volume":"87","author":"Shanmugam","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2019.113714_bib0190","doi-asserted-by":"crossref","first-page":"30361","DOI":"10.1074\/jbc.M111.263350","article-title":"Hepatitis C virus is primed by CD81 protein for low pH-dependent fusion","volume":"286","author":"Sharma","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jviromet.2019.113714_bib0195","first-page":"1","article-title":"Flexible pseudotyping of retrovirus using recombinase-mediated cassette exchange","author":"Soares","year":"2018","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.jviromet.2019.113714_bib0200","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.vaccine.2015.12.015","article-title":"Tetraspanins displayed in retrovirus-derived virus-like particles and their immunogenicity","volume":"34","author":"Soares","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2019.113714_bib0205","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/hep.26566","article-title":"Human serum leads to differentiation of human hepatoma cells, restoration of very-low-density lipoprotein secretion, and a 1000-fold increase in HCV Japanese fulminant hepatitis type 1 titers","volume":"58","author":"Steenbergen","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jviromet.2019.113714_bib0210","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1128\/JVI.00118-08","article-title":"Efficient trans-encapsidation of hepatitis C virus RNAs into infectious virus-like particles","volume":"82","author":"Steinmann","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2019.113714_bib0215","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01708-13","article-title":"Characterization of hepatitis C virus intra- and inter-genotypic chimeras reveals a role of the glycoproteins in virus envelopment","author":"Steinmann","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2019.113714_bib0220","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/hep.21686","article-title":"Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus","volume":"46","author":"Steinmann","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jviromet.2019.113714_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-23593-y","article-title":"LentiPro26: novel stable cell lines for constitutive lentiviral vector production","volume":"8","author":"Tom\u00e1s","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jviromet.2019.113714_bib0230","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1128\/JVI.02700-15","article-title":"A diverse panel of hepatitis C virus glycoproteins for use in vaccine research reveals extremes of monoclonal antibody neutralization resistance","volume":"90","author":"Urbanowicz","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2019.113714_bib0235","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1099\/jgv.0.000537","article-title":"Novel functional hepatitis C virus glycoprotein isolates identified using an optimized viral pseudotype entry assay","volume":"97","author":"Urbanowicz","year":"2016","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jviromet.2019.113714_bib0240","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1128\/JVI.02782-12","article-title":"Subcellular localization and function of an epitope-tagged p7 viroporin in hepatitis C virus-producing cells","volume":"87","author":"Vieyres","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2019.113714_bib0245","doi-asserted-by":"crossref","first-page":"10159","DOI":"10.1128\/JVI.01180-10","article-title":"Characterization of the envelope glycoproteins associated with infectious hepatitis C virus","volume":"84","author":"Vieyres","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2019.113714_bib0250","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","author":"Wakita","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.jviromet.2019.113714_bib0255","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1099\/jgv.0.000608","article-title":"Hepatitis C virus resistance to broadly neutralizing antibodies measured using replication-competent virus and pseudoparticles","volume":"97","author":"Wasilewski","year":"2016","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jviromet.2019.113714_bib0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001087","article-title":"Intracellular proton conductance of the hepatitis C virus p7 protein and its contribution to infectious virus production","volume":"6","author":"Wozniak","year":"2010","journal-title":"PLoS Pathog."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093418304920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093418304920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T10:52:26Z","timestamp":1759056746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093418304920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":52,"alternative-id":["S0166093418304920"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2019.113714","relation":{},"ISSN":["0166-0934"],"issn-type":[{"type":"print","value":"0166-0934"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing Hepatitis C virus pseudoparticles infectivity through p7NS2 cellular expression","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2019.113714","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113714"}}